Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth

NAV as on 25-04-2025

₹ 14.96

1.5%

1D

Inception Returns

26.4%

/yr

Historical NAV & Returns

Absolute

zero opening, trading, fund transfer fee
1292 people have invested ₹ 66.1L in Quant Healthcare Fund Direct Growth in the last three months

About Quant Healthcare Fund Direct Growth

Quant Healthcare Fund Direct Growth is an equity fund. This fund was started on 18 July, 2023. The fund is managed by Sanjeev Sharma, Ankit A. Pande. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Quant Healthcare Fund Direct Growth has ₹370 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
  2. The fund has an expense ratio 0.8.

Returns

Quant Healthcare Fund Direct Growth has given a CAGR return of 26.44% since inception. Over the last 1 year the fund has given a CAGR return of 8.94%.

Holdings

Quant Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Energy, Consumer Defensive, Tech. Its top holdings are Divi's Laboratories Ltd, RPG Life Sciences Ltd, Aster DM Healthcare Ltd Ordinary Shares, Ipca Laboratories Ltd, Torrent Pharmaceuticals Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Quant Healthcare Fund Direct Growth

The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 1000.00. Quant Healthcare Fund Direct Growth has no lock in period.

Quant Healthcare Fund Direct Growth Overview

Expense ratio0.78%
Benchmark
Nifty Healthcare TR INR
AUM₹370 Cr
Inception Date18 July, 2023
Min Lumpsum/SIP₹5000/₹1000
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
140.37%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

Trailing Returns

as on (25-Apr-25)

Period
Quant Healthcare Fund Direct Growth
Nifty 500
sector - healthcare
1M
3.7%
4.5%
1.4%
3M
-3%
3.2%
-1.6%
6M
-8.8%
-2.6%
-1.1%
1Y
8.9%
7.7%
21.8%

Fund Distribution

as on (31-Mar-25)

  • Equity 99.4%

  • Debt & Cash 0.6%

Small cap
52.8%

Large cap
30.6%

Mid cap
14.2%

Sector Allocation

Mar'25

Feb'25

Jan'25

Dec'24

Nov'24

Oct'24

Sep'24

Health
81.9%
Energy
6.9%
Consumer Defensive
6%
Tech
5.2%
All changes are between Jan'25 and Mar'25
Mar'25
Feb'25
Jan'25
Fund Returns
7.00%
-11.70%
-5.11%
Nifty 500
7.25%
-7.88%
-4.01%
  • This fund’s returns stands at 7.00% whereas the fund’s underlying benchmark Nifty 500 returns stands at 7.25% as on Mar'25
  • This fund underperformed Nifty 500 by 0.25% in Mar'25
Parameters
Mar'25
Feb'25
Jan'25
AUM
₹ 369.9 Cr
₹ 347.5 Cr
₹ 402.5 Cr
  • AUM of the fund stands at 369.9 Cr as of Mar'25
  • AUM increased by 22.4 Cr between Mar'25 and Feb'25
Top Stocks bought last month
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 8.18% to 9.22%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 8.18% to 9.22%
Alivus Life Sciences Ltd's allocation increased from 6.27% to 7.2%
Alivus Life Sciences Ltd's allocation increased from 6.27% to 7.2%
Ipca Laboratories Ltd's allocation increased from 7.13% to 7.42%
Ipca Laboratories Ltd's allocation increased from 7.13% to 7.42%
Top Stocks sold last month
Divi's Laboratories Ltd's allocation decreased from 9.67 % to 9.57 %
Divi's Laboratories Ltd's allocation decreased from 9.67 % to 9.57 %
Zydus Lifesciences Ltd's allocation decreased from 7.39 % to 7.02 %
Zydus Lifesciences Ltd's allocation decreased from 7.39 % to 7.02 %
Reliance Industries Ltd's allocation decreased from 6.71 % to 6.69 %
Reliance Industries Ltd's allocation decreased from 6.71 % to 6.69 %
Large Cap allocation has gone down from 31.8% to 30.6%
Large Cap allocation has gone down from 31.8% to 30.6%
Small Cap allocation has gone up from 52.3% to 52.8%
Small Cap allocation has gone up from 52.3% to 52.8%
Mid Cap allocation has gone up from 13.7% to 14.2%
Mid Cap allocation has gone up from 13.7% to 14.2%
Cash allocation has gone down from 0.9% to 0.6%
Cash allocation has gone down from 0.9% to 0.6%

Top 3 Sectors in March were Health, Energy & Consumer Defensive

Mar'25
Health
82%
Energy
7%
Consumer Defensive
6%
Feb'25
Health
82%
Energy
7%
Consumer Defensive
6%
  • Returns %

  • Fund Ratios

  • Overview

Funds
1Y Returns
3Y Returns
5Y Returns
Since Inception
Quant Healthcare Fund Direct Growth
Quant Healthcare Fund Direct Growth
8.94%
-
-
26.44%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
25.47%
25.13%
26.81%
22.86%
SBI Healthcare Opportunities Fund Direct Growth
SBI Healthcare Opportunities Fund Direct Growth
25.35%
24.98%
26.68%
18.44%
LIC MF Healthcare Fund Direct Growth
LIC MF Healthcare Fund Direct Growth
22.27%
17.85%
19.59%
20.34%
  • Gainers

  • Losers

Top Growth Drivers
1M Return
Aster DM Healthcare Ltd
Aster DM Healthcare Ltd
14.8%
Alivus Life Sciences Ltd
Alivus Life Sciences Ltd
3.2%
Fund
Mar'25
Feb'25
Jan'25
No of Holdings
20
20
20
Top 5 Company Concentration
42.8%
41.4%
40.8%
Company having highest exposure
Divi's Laboratories Ltd (9.6%)
Divi's Laboratories Ltd (9.7%)
RPG Life Sciences Ltd (9.3%)
No of Sectors
4
4
5
Top 5 Sectors Concentration
100%
100%
164.7%
Sector having highest exposure
Health (81.9%)
Health (81.5%)
Health (80.9%)
Loading...
We are taking more time than usual
Sanjeev Sharma
Sanjeev Sharma
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Top funds managed
Ankit A. Pande
Ankit A. Pande
Fund Manager of Quant Healthcare Fund Direct Growth, since 18 July 2023
Top funds managed
Fund House
Quant Money Managers Limited
Total Schemes
Total AUM
₹82.15K Cr
as on 31-Mar-2025
Address
6th Floor, Sea Breeze Building,Appasaheb Marathe Marg, Prabhadevi
Phone
022-62955000
Website
help.investor@quant.in

Quant Healthcare Fund Direct Growth Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 26.44% since inception which is more than its category average return of 17.91%
Fund Allocations

Fund Allocations

This fund has an allocation of 99.4% in Equity, 0% in Debt and 0.6% in Cash related instruments
AUM size ₹370 Cr

AUM size ₹370 Cr

This fund has AUM of ₹370 Cr which is less than its category average of ₹ 1821 Cr
Expense Ratio 0.78%

Expense Ratio 0.78%

This fund has an expense ratio of 0.78% which is less than its category average expense ratio of 1.44%

Frequently Asked Questions for Quant Healthcare Fund Direct Growth

The current NAV of Quant Healthcare Fund Direct Growth is ₹14.96 as on 25-Apr-2025.
Existing (Absolute + CAGR) as on 25-Apr-2025.
Quant Healthcare Fund Direct Growth
Absolute Returns
CAGR Returns
1 Month Returns
3.66%
3.66%
6 Month Returns
-8.79%
-8.79%
1 Year Returns
8.94%
8.94%
3 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
0.78% as on March 2025
₹370 Cr as on March 2025
Divi's Laboratories Ltd(9.57%), RPG Life Sciences Ltd(9.28%), Aster DM Healthcare Ltd Ordinary Shares(9.22%), Ipca Laboratories Ltd(7.42%), Torrent Pharmaceuticals Ltd(7.31%) as on March 2025
Health(81.45%), Energy(6.81%), Consumer Defensive(5.94%) as on March 2025
The alpha ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Quant Healthcare Fund Direct Growth
-3
-
-
As on March 2025
The alpha for Quant Healthcare Fund Direct Growth is calculated against Nifty Healthcare TR INR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Quant Healthcare Fund Direct Growth
0.88
-
-
As on March 2025
The Beta for Quant Healthcare Fund Direct Growth is calculated with Nifty Healthcare TR INR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Quant Healthcare Fund Direct Growth
0.2
-
-
As on March 2025
The sharpe ratio for Quant Healthcare Fund Direct Growth is calculated with Nifty Healthcare TR INR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Quant Healthcare Fund Direct Growth for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Quant Healthcare Fund Direct Growth
22
-
-
As on March 2025
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sanjeev Sharma, Ankit A. Pande are the fund managers of Quant Healthcare Fund Direct Growth
The Exit load of Quant Healthcare Fund Direct Growth is 1%